BMO Reiterates Ratings On Eldorado Gold Despite Poor Quarterly Performance

Eldorado Gold (TSX: ELD) is down 8% since it reported its first-quarter financial results on April 28. Eldorado reported revenues of $194.7 million, down 13% year over year, while gross profits fell 38% over the same period to $39.45 million. The firm barely reported an operating profit, reporting $8.13 million, down 82% as the company’s SG&A expense grew 71% year over year.

The company reported a much wider net loss than last year, reporting a net loss of $316.8 million, compared to a net profit of $14.3 million last year. This puts the company’s earnings per share at ($1.74). Free cash flow meanwhile came in at ($26.8) million.

The company said it produced 93,209 ounces of gold, down from 111,742 ounces, while selling 94,472 this quarter meaning the average realized selling gold price was $1,889. The cash costs to produce an ounce of gold went up from $687 to $941, while the all-in sustaining costs grew to $1,347 from $986.

Silver47 Exploration Inc. — sponsored Sponsored · Silver47 Exploration Inc.

Eldorado Gold currently has 11 analysts covering the stock with an average 12-month price target of C$18.31, which represents a 47% upside to the current stock price. Out of the 11 analysts, 1 has a strong buy rating, 6 have buy ratings, 3 have holds and a single analyst has a sell rating on the stock. The highest price target sits at C$22, which signals a 77% upside to the current stock price.

In BMO Capital Markets’ note on the results, they reiterate their outperform rating and C$18 12-month price target on the stock, saying that the real story is lower production results, rather than higher costs and inflation. They call the company results negative, as the company missed all estimates, while inflation hit the company hard.

On the results, Eldorado Gold’s adjusted earnings per share of $0.07 came in below BMO’s estimate of $0.10. While cash costs and all-in sustaining costs came in higher than their estimates of $782 and $1,299, respectively.

Though the company reiterated its full-year 2022 production guidance of 460k to 490k ounces, on top of their cash costs and all-in sustaining costs being reiterated. BMO remarks that their takeaway from the earnings call is that management seemed “less certain about meeting cost guidance for 2022.”

Lastly, the company noted that many things negatively impacted its costs this quarter, resulting in higher input costs which have affected the company’s profitability. BMO notes that now the company has total liquidity of $685 million.

Below you can see BMO’s updated estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Red Cloud Fall Mining Showcase 2026 | Day 1

Can an Old Irish Mine Recover the Silver It Left Behind? | Julian Vickers – Northmin Corporation

Is Gold at $4,000 a Buy Zone or a Breakdown? | David Morgan

Recommended

McLaren Resources Launches Satellite Targeting Program Across Three Timmins Area Gold Properties

Mercado Minerals Lengthens El Triunfo Vein by 190 Metres, Readies 1,500-Metre Zamora Drill Program

Related News

Karora: Haywood Reiterates Ratings After Three Year Guidance Announcement

On June 28th, Karora Resources Inc. (TSX: KRR) announced its three-year production guidance, whereby they...

Wednesday, June 30, 2021, 04:53:00 PM

Cronos Group: Raymond James Sees US$4.10/Share Valuation Just For Ginkgos Partnership

Raymond James recently upgraded Cronos Group (TSX: CRON) (NASDAQ: CRON) to an Outperform 2 rating...

Friday, July 3, 2020, 01:52:39 PM

Inca One Gold Posts Record Production Figures For August 2021

Records continue to be beat by Inca One Gold (TSXV: INCA), whom this morning reported...

Tuesday, September 21, 2021, 08:30:40 AM

Needham Names Green Thumb Industries, Ayr Strategies As 2021 Top Picks

This month, Needham & Company released a 2021 outlook wherein they named Ayr Strategies (CSE:...

Friday, January 1, 2021, 01:45:00 PM

Canaccord Drops Antibe’s Price Target To $0.70 Following Asset Sale

Antibe Therapeutics Inc. (TSX: ATE) recently reported their full-year 2022 results, wherein the company reported...

Friday, July 15, 2022, 02:25:00 PM